Decentralized clinical trials and rare diseases: a Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) perspective | Synapse
April 11, 2023Open Access
Decentralized clinical trials and rare diseases: a Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) perspective
Key Points
Key points are not available for this paper at this time.
Abstract
This paper discusses the planning and conduct of DCTs, which can increase the quality of trials with a specific focus on rare diseases.